Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stavudine: A Review.

Fuchs1, Pollard

  • 1The University of Texas Medical Branch Department of Internal Medicine, Texas USA.

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|December 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Medical problems of an antarctic expedition].

Revue de medecine navale (metropole et outre-mer); travaux scientifiques des medecins et pharmaciens-chimistes de la marine·2014
Same author

X-rays of an exotic bone disease.

Wiener medizinische Wochenschrift (1946)·2010
Same author

Left Ventricular Mapping and Myocardial Revascularization.

Current interventional cardiology reports·2000
Same author

Mechanical Approaches for Myocardial Angiogenesis.

Current interventional cardiology reports·2000
Same author

Ocular plagiocephaly: Author's reply

Ophthalmology·2000
Same author

Ocular plagiocephaly: Author's reply

Ophthalmology·2000
Same journal

Low awareness of HIV status and high proportion of recent infections among young travestis and trans women in Brazil.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2026
Same journal

Rare clinical presentations of paracoccidioidomycosis: Epidemiological, clinical, and microbiological insights from a Brazilian reference center.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2026
Same journal

Immunization against respiratory viruses among dental surgeons: high personal coverage, low involvement in vaccine promotion.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2026
Same journal

Is candidemia mortality inevitable or a consequence of inadequate guideline adherence?

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2026
Same journal

Restoring well-being: quality of life improvements following dolutegravir-based therapy after antiretroviral failure.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2026
Same journal

Etiological profile of male urethritis and genital ulcer disease and antimicrobial susceptibility of Neisseria gonorrhoeae in Southeastern Brazil.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2026
See all related articles

Stavudine is a well-tolerated HIV-1 treatment, effective in combination regimens. Peripheral neuropathy is its main side effect, but it is reversible. Avoid combining with zidovudine due to potential reduced efficacy and increased side effects.

Area of Science:

  • Antiviral Therapy
  • HIV-1 Management
  • Nucleoside Analogues

Background:

  • Stavudine is the fourth approved nucleoside analog for HIV-1 management in the US.
  • It is a dideoxy analog of thymidine, structurally similar to zidovudine.
  • Standard adult dosage is 40mg twice daily, adjusted for toxicity or renal insufficiency.

Purpose of the Study:

  • To review the efficacy and safety profile of stavudine in HIV-1 treatment.
  • To evaluate stavudine's role in combination antiviral therapy.
  • To assess potential drug interactions and adverse effects.

Main Methods:

  • Review of clinical studies and trial data on stavudine.
  • Analysis of stavudine's pharmacokinetic and pharmacodynamic properties.

Related Experiment Videos

  • Evaluation of stavudine's efficacy in reducing viral load and its safety profile.

    • Main Results:

    • Stavudine is generally well-tolerated with infrequent hematological toxicity.
    • Peripheral neuropathy is the dose-limiting adverse effect, typically reversible.
    • Synergistic activity observed in vitro with didanosine, lamivudine, nevirapine, and saquinavir.
    • Combination therapy with stavudine can reduce viral load by 2 log(10) copies/ml.

    Conclusions:

    • Stavudine is an effective component of combination HIV-1 regimens.
    • Peripheral neuropathy necessitates careful monitoring and potential dose adjustment.
    • Stavudine should be used as an alternative to zidovudine in combination regimens due to potential adverse interactions.